Please see below all current breast cancer clinical trials of the Central Coast Cancer Centre.
Name: ELIMINATE
Randomised phase II trial of neoadjuvant chemotherapy +/- concurrent aromatase inhibitor endocrine therapy to down-stage large oestrogen receptor-positive breast cancer.
Protocol Number: ANZ1401
Principal Investigator: Dr Susan Tiley
Study Coordinator: Michelle Dixon
Status: Recruiting
Condition: Breast Cancer
More information about ELIMINATE
Name: OLYMPIA
A randomized, double-blind, parallel group, placebo-controlled multicenter phase III study to assess the efficacy and safety of olaparib versus placebo as adjuvant treatment in patients with high-risk germline BRCA mutated HER2-negative breast cancer who have completed definitive local and systemic neoadjuvant/adjuvant treatment.
Protocol Number: DO81CC0006
Principal Investigator: Dr Susan Tiley
Study Coordinator: Leonie Kelly
Status: Recruiting
Condition: Breast Cancer
More information about OlympiA
More information
For more information about medical oncology clinical trials, please contact the Nurse Unit Manager on 02 4320 9890 or see:
Research and Clinical Trials
